ABVC BioPharma, Inc. Deferred Revenue, Revenue Recognized
ABVC BioPharma, Inc. (ABVC) reported Deferred Revenue, Revenue Recognized of $200.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-04-30.
Financial Statements › Income Statement › Other Income
us-gaap:DeferredRevenueRevenueRecognized1 · last filed 2025-08-13
- ABVC BioPharma, Inc. deferred revenue, revenue recognized for the quarter ending 2025-03-31 was $200.00K.
- ABVC BioPharma, Inc. deferred revenue, revenue recognized for the quarter ending 2024-09-30 was $200.00K.
| Period end | Deferred Revenue, Revenue Recognized 3 month | Deferred Revenue, Revenue Recognized 9 month | Deferred Revenue, Revenue Recognized 12 month |
|---|---|---|---|
| 2025-03-31 | $200.00K 10-Q · filed 2025-04-30 | ||
| 2024-12-31 | $200.00K 10-Q · filed 2025-08-13 | ||
| 2024-09-30 | $200.00K 10-Q · filed 2024-11-14 | $200.00K 10-Q · filed 2024-11-14 |